MG
VNDA icon

Michael Gelband’s Vanda Pharmaceuticals VNDA Stock Holding History

Michael Gelband’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Sell
26,637
-7,801
-23% -$51K ﹤0.01% 1436
2026
Q1 		$238K Buy
+34,438
New +$266K ﹤0.01% 1357
2025
Q4 		– Sell
-68,103
Closed -$340K – 2108
2025
Q3 		$340K Buy
68,103
+46,561
+216% +$216K ﹤0.01% 1277
2025
Q2 		$102K Sell
21,542
-57,618
-73% -$252K ﹤0.01% 1356
2025
Q1 		$363K Buy
79,160
+47,654
+151% +$222K ﹤0.01% 1191
2024
Q4 		$151K Sell
31,506
-94,144
-75% -$452K ﹤0.01% 1384
2024
Q3 		$589K Buy
+125,650
New +$674K ﹤0.01% 1134
2023
Q4 		– Sell
-150,399
Closed -$650K – 2092
2023
Q3 		$650K Buy
150,399
+76,577
+104% +$425K 0.01% 1145
2023
Q2 		$486K Buy
+73,822
New +$473K ﹤0.01% 1370
2022
Q4 		– Sell
-10,099
Closed -$100K – 2173
2022
Q3 		$100K Sell
10,099
-128,077
-93% -$1.35M ﹤0.01% 1745
2022
Q2 		$1.51M Buy
138,176
+65,045
+89% +$674K 0.02% 912
2022
Q1 		$827K Buy
73,131
+28,316
+63% +$372K 0.01% 1265
2021
Q4 		$703K Buy
+44,815
New +$781K 0.01% 1245
2021
Q3 		– Sell
-17,034
Closed -$366K – 2679
2021
Q2 		$366K Sell
17,034
-37,368
-69% -$669K ﹤0.01% 1616
2021
Q1 		$817K Buy
54,402
+41,515
+322% +$672K 0.01% 1040
2020
Q4 		$169K Buy
+12,887
New +$155K ﹤0.01% 1767
2020
Q1 		– Sell
-26,968
Closed -$443K – 1673
2019
Q4 		$443K Buy
+26,968
New +$408K 0.01% 931

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's VNDA Position: Q2 2026 in Review

Michael Gelband reduced its Vanda Pharmaceuticals (VNDA) stake by 23% in Q2 2026, selling an estimated $51K and leaving 26,637 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Michael Gelband first reported a position in VNDA in Q4 2019 and has held it in 17 quarters since. The position peaked at $1.51M in Q2 2022. 171 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Michael Gelband held 26,637 shares of Vanda Pharmaceuticals worth $163K as of Q2 2026.
  • Michael Gelband sold 7,801 Vanda Pharmaceuticals shares in Q2 2026, an estimated $51K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1436 holding.
  • Michael Gelband first reported a position in Vanda Pharmaceuticals in Q4 2019 and has held it in 17 quarters since.
  • Michael Gelband's Vanda Pharmaceuticals position peaked at $1.51M in Q2 2022.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.